Telomeres are shorter in placental trophoblasts of pregnancies complicated with intrauterine growth restriction (IUGR)

Early Human Development

Volumn 86, Issue 7, 2010, Pages 451-456

  Biron Shental, Tal ^a,c   Sukenik Halevy, Rivka ^a,c   Goldberg Bittman, Lilach ^a,b   Kidron, Dvora ^a,c   Fejgin, Moshe D ^a,c   Amiel, Aliza ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

IUGR; Telomeres; Trophoblasts

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANEUPLOIDY; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PLACENTA INSUFFICIENCY; PROTEIN EXPRESSION; TELOMERE; TROPHOBLAST;

FEMALE; FETAL GROWTH RETARDATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; PLACENTAL INSUFFICIENCY; PREGNANCY; TELOMERE; TROPHOBLASTS;

EID: 77955280810     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.06.002     Document Type: Article

References (51)

1. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during aging of human fibroblasts. Nature 1990, 345:458-460.
2. Counter C.M., Avilion A.A., LeFeuvre C.E., et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, 11:1921-1929.
3. Greider C.W. Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet Dev 1994, 4:203-211.
4. Kim N.W., Piatyszek M.A., Prowse K.R., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
5. Shay J.W., Bacchetti S.A. A survey to telomerase activity in human cancer. Eur J Cancer 1997, 33:787-791.
6. de Lange T., Shiue L., Myers R.M., et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990, 10:518-527.
7. Keefe D.L., Marquard K., Liu L. The telomere theory of reproductive senescence in women. Curr Opin Obstet Gynecol 2006, 18:280-285.
8. Allsopp R.C., Vaziri H., Patterson C., et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89:10114-10118.
9. Houben J.M., Moonen H.J., van Schooten F.J., Hageman G.J. Telomere length assessment: Biomarker of chronic oxidative stress?. Free Radical Bil Med 2008, 44:235-246.
10. Mai S., Garini Y. The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 2006, 97:904-915.
11. Muller H.J. The remaking of chromosomes. Collecting Net 1938, 13(1):181-198.
12. McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941, 26(2):234-282.
13. McClintock B. The fusion of broken ends of chromosomes following nuclear fusion. Proc Natl Acad Sci USA 1942, 28(11):458-463.
14. Chuang T.C., Moshir S., Garini Y., et al. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2004, 3:2-12.
15. Blasco M.A., Lee H.W., Hande M.P., et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
16. Rudolph K.L., Chang S., Lee H.W., et al. Longevity, stress response and cancer in aging telomerase-deficient mice. Cell 1999, 96:701-712.
17. Hug N., Lingner J. Telomere length homeostasis. Chromosoma 2006, 115(6):413-425.
18. Yan P., Benhattar J., Seelentag W., Stehle J.C., Bosman F.T. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 2004, 121(5):391-397.
19. Volpi A., Bravaccini S., Medri L., Cerasoli S., Gaudio M., Amadori D. Usefulness of immunological detection of the human telomerase reverse transcriptase. Cell Oncol 2005, 27:347-353.
20. Miller J., Turan S., Baschat A.A. Fetal growth restriction. Semin Perinatol 2008, 32(4):274-280.
21. Barker D.J. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006, 49(2):270-283.
22. Simmons R. Perinatal programming of obesity. Semin Perinatol 2008, 32(5):371-374.
23. Redline R.W. Placental pathology: a systematic approach with clinical correlations. Placenta 2008, 29:S86-S91.
24. Salafia C.M., Charles A.K., Maas E.M. Placenta and fetal growth restriction. Clin Obstet Gynecol 2006, 49(2):236-256.
25. Martenes U.M., Zijlmans J.M., Poon S.S., et al. Short telomeres on human chromosome 17p. Nat Genet 1998, 18:76-80.
26. Poon S.S., Martenes U.M., Ward R.K., Landsdrop P.M. Telomere length measurements using digital fluorescence microscopy. Cytometry 1999, 36:267-278.
27. Svenson U., Roos G. Telomere length as a biological marker in malignancy. Biochem. et Biophys. Acta 2009, 1792:317-323.
28. De Pauw E.S.D., Verwoerd N.P., Duinkerken N., et al. Assessment of telomere length in hematopoietic interphase cells using in situ hybridization and digital fluorescence microscopy. Cytom A 1998, 32:163-169.
29. Slijepcevic P. Telomere length measurement by Q-FISH methods. Cell Sci 2001, 23:17-22.
30. Ferlicot S., Youssef N., Feneux D., Delhommeau F., Paradis V., Bedossa P. Measurement of telomere length on tissue sections using quantitative fluorescence in situ hybridization (Q-FISH). J Pathol 2003, 200(5):661-666.
31. O'Sullivan J.N., Finley J.C., Risques R.A., et al. Telomere length assessment in tissue sections by quantitative FISH: image analysis algorithms. Cytom A 2004, 58(2):120-131.
32. Narath R., Lorch T., Greulich-Bode K.M., Boukamp P., Ambros P.F. Telomere length measurements in interphase nuclei by IQ-FISH. Cytometry 2005, 68(2):113-120.
33. Kitay-Cohen Y., Goldberg-Bittman L., Hadary R., Fejgin M.D., Amiel A. Telomere length in Hepatitis C. Cancer Genet Cytogenet 2008, 187(1):34-38.
34. Cairney C.J., Keith W.N. Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. Biochimie 2008, 90(1):13-23.
35. Benn P. Trisomy 16 and trisomy 16 Mosaicism: a review. Am J Med Genet 1998, 79(2):121-133.
36. Yong P.J., Barrett I.J., Kalousek D.K., Robinson W.P. Clinical aspects, prenatal diagnosis, and pathogenesis of trisomy 16 mosaicism. J Med Genet 2003, 40(3):175-182.
37. Hiyama K., Hirai Y., Kyoizumi S., et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995, 155(8):3711-3715.
38. Chiu C.P., Dragowska W., Kim N.W., et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996, 14(2):239-248.
39. Rosso P. Placenta as an ageing organ. Curr Concept Nutr 1976, 4:23-41.
40. Kyo S., Takakura M., Tanaka M., et al. Expression of telomerase activity in human chorion. Biochem Biophys Res Commun 1997, 241:498-503.
41. Chu Cheh R.J., Huang SC C.T., Chow S.N., Hsieh C.Y. Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies. Hum Reprod 2002, 17:463-468.
42. Izutsu T., Izutsu N., Iwane A., et al. Expression of human telomerase reverse transcriptase and correlation with telomerase activity in placentas with and without intrauterine growth retardation. Acta Obstet et Gynecol 2006, 85:3-11.
43. Allsopp R., Shimoda J., Easa D., Ward K. Long telomeres in the mature human placenta. Placenta 2007, 28(4):324-327.
44. Izutsu T., Kudo T., Sato T., et al. Telomerase activity in human chorionic villi and placenta determined by TRAP and in situ TRAP assay. Placenta 1998, 19:613-618.
45. Davy P., Nagata M., Bullard P., Fogelson N.S., Allsopp R. Fetal growth restriction is associated with accelerated telomere shortening and increased expression of cell senescence markers in the placenta. Placenta 2009, 30(6):539-542.
46. Akkad A., Hastings R., Konje J.C., Bell S.C., Thurston H., Williams B. Telomere length in small-for-gestational-age babies. BJOG 2006, 113(3):318-323.
47. DePinho R.A., Polyak K. Cancer chromosomes in crisis. Nat Genet 2004, 36(9):932-934.
48. Dynek J.N., Smith S. Resolution of sister telomere association is required for progression through mitosis. Science 2004, 304(5667):97-100.
49. Goldberg-Bittman L., Kitay-Cohen Y., Quitt M., Hadary R., Fejgin M.D., Yukla M., et al. Telomere aggregates in non-Hodgkin lymphoma (NHL) patients at different disease stages. Cancer Genet Cytogenet 2008, 184:105-108.
50. Amiel A., Fejgin M.D., Goldberg-Bittman L., Sharoni R., Kitay-Cohen Y. Telomeres aggregates in hepatitis C patients. Cancer Inves 2009, 27(6):650-654.
51. Sukenik-Halevy R., Fejgin M.D., Kidron D., et al. Telomere aggregates formation in placenta specimens of pregnancies complicated with pre-eclampsia. Cancer Genet Cytogenet 2009, 195(1):27-30.